Fertility preservation in Hodgkin’s lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era

In total, 80%–90% of Hodgkin’s lymphoma (HL) patients are curable with combination chemoradiotherapy. Due to improvements in therapeutic strategies, 50% of all relapsed/refractory patients may undergo complete clinical responses and have long-term survival. Treatment options for HL are effective, bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Traila, Alexandra, Dima, Delia, Achimas-Cadariu, Patriciu, Micu, Romeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005299/
https://www.ncbi.nlm.nih.gov/pubmed/29942153
http://dx.doi.org/10.2147/CMAR.S154819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005299/
https://www.ncbi.nlm.nih.gov/pubmed/29942153
http://dx.doi.org/10.2147/CMAR.S154819

Ejemplares similares